Multiple Sclerosis Clinical Trial

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

Summary

The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illness and missed medications.

View Full Description

Full Description

Fluctuations in MS symptoms in women with RR-MS might be affected by a variety of factors. To determine which factors are important, we are asking subjects to fill out a diary and calendar on a daily basis for 90 days. After an initial instructional meeting over the phone, the materials are filled out at home and returned monthly via postage-paid envelopes provided by the study. Compensation ($10 gift card) is sent after each monthly diary is received. The diary includes a list of symptoms and a rank scale for the women to show subtle changes in MS symptoms. The calendar allows the subject to denote additional factors such as stress, hormonal cycles, illnesses or immunizations and changed or missed medications. We anticipate that statistical analysis will reveal which of these factors affect women with relapsing-remitting multiple sclerosis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

females
diagnosed with relapsing-remitting multiple sclerosis

Exclusion Criteria:

male
no diagnosis of relapsing-remitting MS
diagnosis of any other autoimmune disease or fibromyalgia
peri-, post-, or surgically menopausal
pregnant within past year or nursing
history of chemotherapy
on experimental medications
treatment with steroids in the last 30 days

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

80

Study ID:

NCT00919217

Recruitment Status:

Recruiting

Sponsor:

University of Louisville

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Louisville (recruiting nationwide)
Louisville Kentucky, 40292, United States More Info
Cynthia Corbitt, PhD
Contact
502-852-3915
[email protected]
Cynthia Corbitt, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

80

Study ID:

NCT00919217

Recruitment Status:

Recruiting

Sponsor:


University of Louisville

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.